Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 7, 2026; 32(25): 118842
Published online Jul 7, 2026. doi: 10.3748/wjg.118842
Published online Jul 7, 2026. doi: 10.3748/wjg.118842
Figure 7 Immunofluorescence staining of additional gastric intestinal metaplasia patients.
Positive staining for FOLH1 (red color) was significantly increased in the epithelium of the [non-progression group (N)] N1-intestinal metaplasia (IM) group compared to the progression group (P group) P1-IM group. cP < 0.001. N group: Non-progression group; P group: Progression group; IM: Intestinal metaplasia; IOD: Integrated optical density; DAPI: 4’,6-diamidino-2-phenylindole.
- Citation: He S, Guo XF, Wang Y, Bai JQ, Wang JP, Shi JH, Shi YY, Yuan J, Wei W, Yang Y, Shi XH, Feng Y, Ding X, Gao W, Lu D, Zhou WX, Zhang P. FOLH1 as a novel biomarker for risk stratification in gastric intestinal metaplasia. World J Gastroenterol 2026; 32(25): 118842
- URL: https://www.wjgnet.com/1007-9327/full/v32/i25/118842.htm
- DOI: https://dx.doi.org/10.3748/wjg.118842